Capricor Therapeutics Inc (NASDAQ:CAPR)
| 4.57 Delayed Data As of 4:00pm ET |  +0.17 / +3.86%Today’s Change | 3.30 Today|||52-Week Range 6.58 | +18.39% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 3.8M | 3.2M | 1.6M | 671.4K | |
| Depreciation And Amortization | 110.9K | 134.6K | 144.2K | 157.7K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 18.0M | 20.9M | 15.4M | 16.9M | ||
| Research And Development | 13.8M | 16.0M | 10.8M | 12.1M | ||
| Total Operating Expenses | 18.2M | 21.0M | 15.6M | 17.0M | ||
| Non-Operating Expenses | Operating Income | -14.4M | -17.8M | -14.0M | -16.4M | |
| Extraordinary Credit | 0.00 | 0.00 | 15.7M | 0.00 | ||
| Extraordinary Charge | 0.00 | -1.5M | 0.00 | 0.00 | ||
| Interest Expense On Debt | 248.6K | 344.7K | 398.8K | 0.00 | ||
| Other Expenses | 1.8M | 838.5K | 1.1M | 1.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -12.9M | -18.8M | 2.4M | -15.2M | |
| Net Income | -12.9M | -18.8M | 2.4M | -15.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.6M | 1.9M | 2.3M | 2.9M | |
| Shares To Calculate EPS Diluted | 1.6M | 1.9M | 2.7M | 2.9M | ||
| Earnings Per Share | EPS | -$8.10 | -$10.10 | $0.90 | -$5.20 | |
| EPS Diluted | -$8.10 | -$10.10 | $0.90 | -$5.17 | ||
